| Eric B Richmond, CRNA | |
|
1319 Punahou St, Honolulu, HI 96826-1001 | |
| (808) 986-8000 | |
| Not Available |
| Full Name | Eric B Richmond |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 46 Years |
| Location | 1319 Punahou St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447375266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | APRN786 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center Of El Paso | El paso, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| El Paso County Hospital District | 2365431509 | 118 |
News Archive
Increasing MR exam efficiency, Toshiba America Medical Systems, Inc.'s advanced M-Power interface has received FDA clearance. M-Power is a customizable MR system user interface enabling technologists to streamline and accelerate scanning processes and enhance diagnoses.
A report published today by the national deafblind charity, Sense, highlights the health inequalities and barriers faced by deafblind people accessing healthcare in England.
In this post in the Guardian's "Poverty Matters" blog, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin discusses a family planning summit to be held in London next month, writing the UNFPA "is supporting the initiative so that it can gain traction and support among other donors and UN member countries."
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
› Verified 6 days ago
| Entity Name | El Paso County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316936990 PECOS PAC ID: 2365431509 Enrollment ID: O20040511001452 |
News Archive
Increasing MR exam efficiency, Toshiba America Medical Systems, Inc.'s advanced M-Power interface has received FDA clearance. M-Power is a customizable MR system user interface enabling technologists to streamline and accelerate scanning processes and enhance diagnoses.
A report published today by the national deafblind charity, Sense, highlights the health inequalities and barriers faced by deafblind people accessing healthcare in England.
In this post in the Guardian's "Poverty Matters" blog, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin discusses a family planning summit to be held in London next month, writing the UNFPA "is supporting the initiative so that it can gain traction and support among other donors and UN member countries."
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
› Verified 6 days ago
| Entity Name | Anesthesia Associates Of El Paso Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942626908 PECOS PAC ID: 0941426357 Enrollment ID: O20140721001702 |
News Archive
Increasing MR exam efficiency, Toshiba America Medical Systems, Inc.'s advanced M-Power interface has received FDA clearance. M-Power is a customizable MR system user interface enabling technologists to streamline and accelerate scanning processes and enhance diagnoses.
A report published today by the national deafblind charity, Sense, highlights the health inequalities and barriers faced by deafblind people accessing healthcare in England.
In this post in the Guardian's "Poverty Matters" blog, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin discusses a family planning summit to be held in London next month, writing the UNFPA "is supporting the initiative so that it can gain traction and support among other donors and UN member countries."
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric B Richmond, CRNA 98-715 Iho Pl, Building 4 Apt 1501, Aiea, HI 96701-2514 Ph: (808) 484-0608 | Eric B Richmond, CRNA 1319 Punahou St, Honolulu, HI 96826-1001 Ph: (808) 986-8000 |
News Archive
Increasing MR exam efficiency, Toshiba America Medical Systems, Inc.'s advanced M-Power interface has received FDA clearance. M-Power is a customizable MR system user interface enabling technologists to streamline and accelerate scanning processes and enhance diagnoses.
A report published today by the national deafblind charity, Sense, highlights the health inequalities and barriers faced by deafblind people accessing healthcare in England.
In this post in the Guardian's "Poverty Matters" blog, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin discusses a family planning summit to be held in London next month, writing the UNFPA "is supporting the initiative so that it can gain traction and support among other donors and UN member countries."
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
› Verified 6 days ago
Peter Loving, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-1000 | |
Debra J Brittain, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Cynthia K. Poe, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Diane Martelli, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-547-4929 Fax: 808-547-4044 | |
Ms. Jessica Hammonds Deery, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Lauren Rebecca Ellis James, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Anna P. Doyle, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 |